Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vet groups warn CMA remedies could cause welfare issues
The vet groups raised concerns over remedies including longer prescription periods and the use of generic medicines.
BVA and others set out possible unintended consequences.

A coalition of veterinary groups has warned that unintended consequences from the ongoing review into the veterinary sector by the Competition and Markets Authority (CMA) could lead to animal welfare issues.

The British Veterinary Association (BVA), the British Small Animal Veterinary Association (BSAVA), the Society of Practising Veterinary Surgeons (SPVS) and the Veterinary Management Group (VMG) set out their concerns in their response to the CMA's consultation on its issues statement.

The CMA's issues statement listed the Inquiry Group's initial theories about issues surrounding competition in the veterinary sector and potential remedies.

In their joint response, which they have made public, the veterinary groups set out a number of areas where they believe the CMA's proposed remedies could have unintended negative impacts.

The groups state that they have significant concerns about the idea of mandating longer prescriptions periods. They warn it could cause a serious threat to animal welfare issues by possibly leading to antimicrobial resistance, side effects going unmonitored, and conditions worsening without being seen.

They also argue that the proposal that veterinary practices should send annual 'wake-up' letters to clients to prompt them to reconsider their choice of practice could undermine the vet-client-patient relationship and continuity of care. This could increase the risks posed by miscommunication, lack of comprehensive medical records, and fragmented care.

On the topic of generic medicines, the groups have reminded the CMA that veterinary surgeons must follow the Veterinary Medicines Regulations and prescribe according to the Cascade. Suggesting that unlicensed generic medication is equivalent to licensed veterinary products would be irresponsible, the groups say.

Anna Judson, BVA president, said: “Cleary these are unintended consequences, but they do highlight the importance of continued engagement between the CMA and the profession as the investigation progresses to ensure the veterinary voice is heard and unintended consequences are avoided.”

The full response can be read here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.